Previous Close | 2.6200 |
Open | 2.5400 |
Bid | 2.5900 |
Ask | 2.6700 |
Strike | 65.00 |
Expire Date | 2024-06-21 |
Day's Range | 2.1300 - 3.0000 |
Contract Range | N/A |
Volume | |
Open Interest | 283 |
Gilead stock pared its gains Friday after beating first-quarter sales forecasts on the back of its Covid treatment, Veklury.
Gilead (GILD) reports narrower-than-expected loss in the first quarter. Its sales beat estimates on higher HIV, Oncology and Liver Disease sales.
Q1 2024 Gilead Sciences Inc Earnings Call